drugset / Trial / NCT01857596

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety

NCT01857596

Phase 1/2 Completed 30 enrolled S1 Biopharma, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate whether Lorexys is effective and safe to treat premenopausal women who have lost their sexual desire to a distressing degree.

Timeline

Start
2013-04
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule Oral
Subject Trazodone Small molecule Oral